Nadine M Magoski

Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer

Eric X. Chen, Derek J. Jonker, Jonathan M. Loree et al. · JAMA Oncology · 2020 · 398 citations · Full text

Medicine, Oncology, Pharmacology +17

Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial

Derek J. Jonker, Louise Nott, Takayuki Yoshino et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 168 citations

Medicine, Oncology, Pharmacology +7

Phase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in Patients With Metastatic, Chemotherapy-Refractory, Wild-Type <i>K-RAS</i> Colorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 Trial

Lillian L. Siu, Jeremy Shapiro, Derek J. Jonker et al. · Journal of Clinical Oncology · 2013 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17

A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10

T. Winton, Robert B. Livingston, D. Johnson et al. · Journal of Clinical Oncology · 2004 · 124 citations

Medicine, Oncology, Cancer Drug Toxicity Management +16

Identification of Human Lung and Skin Proteins Conjugated with Hexamethylene Diisocyanate <i>in Vitro</i> and <i>in Vivo</i>

Adam V. Wisnewski, Ranjana Srivastava, CHRISTINA HERICK et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 119 citations

Pharmacy, Biochemistry, Toxicology +13